Podcast: Regulus Therapeutics and Outsourcing Strategies - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and Outsourcing Strategies


blog comments powered by Disqus


Focusing on outsourcing strategies, BioPharm International interviews for a second time Bal Bhat, senior director and head of chemistry at Regulus, a company that develops and manufactures oligonucleotides to support the discovery and development of microRNA therapeutics. Bhat discusses the reasoning behind Regulus’ choice of outsourcing partners and how working closely with those partners to harmonize methodology and data quality is crucial. Bhat also describes how engaging outsourcing partners with the excitement of microRNA technology enabled an improved working relationship with shared goals. Posted Nov. 2011.

Related article on Perspectives in MicroRNA Therapeutics

Podcast: Dr. Bhat focuses on microRNA Drug Delivery

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines

Click here